Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BORTEZOMIB KOANAA 2,5 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/BORTEZOMIB KOANAA 2,5 MG/ML SOLUCION INYECTABLE

Approved

STANDARD

BORTEZOMIB KOANAA 2,5 MG/ML SOLUCION INYECTABLE

Koanaa Healthcare Spain S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 31, 2024
Approval ID: 94e0763d5a928783
Company: Koanaa Healthcare Spain S.L.
Type: Standard

Approval Details

Approval Id: 94e0763d5a928783
Drug Cima Aemps Name: BORTEZOMIB KOANAA 2,5 MG/ML SOLUCION INYECTABLE
Register Number: 89751
Holder Company Name: Koanaa Healthcare Spain S.L.
Marketing Company Name: Koanaa Healthcare Spain S.L.
Authorization Date: 2024-07-31
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 2,5 MG/ML
Route Of Administration: VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Koanaa Healthcare Spain S.L.

Active Ingredients

BORTEZOMIB

2,5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 31, 2024

Approval ID

94e0763d5a928783

Type

Standard

Back to CIMA-AEMPS Approvals